This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
NovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NVCRPositive Net Change LCTXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SoFi Technologies (SOFI) Soars 11.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
SoFi Technologies (SOFI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
SOFINegative Net Change LFTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SoundHound AI (SOUN) Soars 5.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
SoundHound AI (SOUN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SOUNNegative Net Change CRNCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
After Golden Cross, HCI Group (HCI)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HCIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Clipper Realty (CLPR) Soars 9.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Clipper Realty (CLPR) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might help the stock continue moving higher in the near term.
CLPRPositive Net Change NNNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ClearPoint Neuro (CLPT) Soars 6.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
ClearPoint Neuro (CLPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CLPTNo Net Change NSPRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
AirSculpt Technologies (AIRS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AIRSPositive Net Change NNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Coinbase Global (COIN) Moves 11.3% Higher: Will This Strength Last?
by Zacks Equity Research
Coinbase Global (COIN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
COINPositive Net Change FLYWPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Westrock Coffee Company (WEST) Moves 10.8% Higher: Will This Strength Last?
by Zacks Equity Research
Westrock Coffee Company (WEST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
WESTNegative Net Change AKO.BNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Upstart (UPST) Moves 15.0% Higher: Will This Strength Last?
by Zacks Equity Research
Upstart (UPST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UPSTPositive Net Change PRAANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Castle Biosciences (CSTL): Can Its 9.4% Jump Turn into More Strength?
by Zacks Equity Research
Castle Biosciences (CSTL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CSTLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Sirius XM (SIRI): Can Its 7.9% Jump Turn into More Strength?
by Zacks Equity Research
Sirius XM (SIRI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
SIRIPositive Net Change TSQPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Wolfspeed (WOLF): Can Its 20.8% Jump Turn into More Strength?
by Zacks Equity Research
Wolfspeed (WOLF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
WOLFNegative Net Change VSHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ocular Therapeutix (OCUL) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Ocular Therapeutix (OCUL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OCULNo Net Change FDMTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Lyft (LYFT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
LYFTNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Crocs (CROX) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
CROXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Northeast Community Bancorp (NECB): Can Its 6.6% Jump Turn into More Strength?
by Zacks Equity Research
Northeast Community Bancorp (NECB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
NECBPositive Net Change VLYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AXGNNegative Net Change ITGRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
W.W. Grainger (GWW) Surges 5.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
W.W. Grainger (GWW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
GWWPositive Net Change SITEPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bicycle Therapeutics (BCYC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BCYCPositive Net Change VYGRNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Lyft (LYFT) Soars 9.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lyft (LYFT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
LYFTNegative Net Change TSLANegative Net Change LPSNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Uber (UBER) Moves 10.8% Higher: Will This Strength Last?
by Zacks Equity Research
Uber (UBER) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
UBERNegative Net Change BIDUNegative Net Change TSLANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Roku (ROKU) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ROKUPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Arbor Realty Trust (ABR) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
ABRPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PTCTPositive Net Change USNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today